Skip to content

Clinical trials

Phase 1 Primary Myelofibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Phase: Phase 1 Clear all

141 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20023
20031
20042
20056
20065
20077
20085
20093
20104
20116
20123
20143
20158
20166
20172
20186
20196
20207
20214
20228
20236
20248
20254
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68
Recruiting26
Terminated19
Active, not recruiting16
Withdrawn7
Unknown status4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.7
Incyte Corporation7
National Cancer Institute (NCI)7
City of Hope Medical Center6
Northwestern University5
Novartis Pharmaceuticals5
Case Comprehensive Cancer Center4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
AbbVie3
M.D. Anderson Cancer Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis141
Myeloproliferative Disorders59
Leukemia, Myeloid, Acute58
Leukemia, Myelomonocytic, Chronic50
Myelodysplastic Syndromes50
Precursor Cell Lymphoblastic Leukemia-Lymphoma49
Leukemia, Lymphocytic, Chronic, B-Cell45
Thrombocythemia, Essential43
Polycythemia Vera41
Lymphoma, Non-Hodgkin40

Trials

Showing 26 to 50 of 141. Each trial links to its page on Pharma Observatory.

41 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.